| Maria Cynthia Yango Eugenio, MD | |
|
1411 N. Mchenry Road, Suite 126, Buffalo Grove, IL 60089 | |
| (847) 821-1071 | |
| (847) 821-1077 |
| Full Name | Maria Cynthia Yango Eugenio |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 45 Years |
| Location | 1411 N. Mchenry Road, Buffalo Grove, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881766947 | NPI | - | NPPES |
| 370005563 | Other | IL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 336-037275 (36-07369 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Cynthia Yango Eugenio, MD Po Box 959116, Hoffman Estates, IL 60195-9116 Ph: (815) 544-6159 | Maria Cynthia Yango Eugenio, MD 1411 N. Mchenry Road, Suite 126, Buffalo Grove, IL 60089 Ph: (847) 821-1071 |
News Archive
It is not primary tumors that are responsible for the majority of cancer deaths, but rather their metastases. Physiologists and neuropathologists from the University of Zurich have now identified the origin of metastasis formation, thereby becoming the first to reveal the pathway of metastasizing intestinal cancer cells out of the blood stream. The results allow new approaches in the development of cancer therapies.
When doctors become invested in an outpatient surgery center, they perform on average twice as many surgeries as doctors with no such financial stake, according to a new study from the University of Michigan Health System.
When paramedics rush to the scene of a multi-car pileup or a terror attack, their first task is to assess who needs immediate care. But blood hemorrhaging can obscure damage, and the gruesome mess means paramedics can't always determine who should be treated first.
On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.
› Verified 7 days ago
Dr. Leo Gutt, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3011 Bayberry Dr, Buffalo Grove, IL 60089 Phone: 630-542-7895 |